A detailed history of Seven Mile Advisory transactions in Merck & Co., Inc. stock. As of the latest transaction made, Seven Mile Advisory holds 4,743 shares of MRK stock, worth $483,169. This represents 0.43% of its overall portfolio holdings.

Number of Shares
4,743
Previous 4,638 2.26%
Holding current value
$483,169
Previous $612 Million 4.07%
% of portfolio
0.43%
Previous 0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $12,999 - $13,960
105 Added 2.26%
4,743 $587 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $4,869 - $5,673
43 Added 0.94%
4,638 $612 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $17,932 - $19,514
179 Added 4.05%
4,595 $501 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $17,604 - $19,550
-171 Reduced 3.73%
4,416 $455 Million
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $498,194 - $543,009
4,587 New
4,587 $529 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.